| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |